⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Data from Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid Tumors

Shiyun Xian Xiaona Chen Sihang Ren X.M. Chen Hangxiang Wang

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplementary Methods, Supplementary Figures S1–S50, and Supplementary Tables S1–S3.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xian et al. (2024) studied this question.

synapsesocial.com/papers/68e587eeb6db643587523ef8 https://doi.org/10.1158/0008-5472.27024140

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data from Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid Tumors2024
2Data from Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid Tumors2024
3Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma2024
4Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma2024
5Supplementary Data from Targeting the immunoglobulin IGSF9 enhances anti-tumor T cell activity and sensitivity to anti-PD-1 immunotherapy2024

More related papers

Supplementary Data from Targeting the immunoglobulin IGSF9 enhances anti-tumor T cell activity and sensitivity to anti-PD-1 immunotherapy2024
Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer2024
Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer2024